biomodal at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

biomodal brings 2 presentations to ASHG 2026 in Montréal, and exhibits at Booth 1409. Its program at this meeting centres on multiomic sequencing, methylation analysis, and clinical genomics. Its presentations show how 6-base sequencing reveals regulatory biology and functional genomic readouts in difficult clinical samples.

Organization

ASHG 2026 Attendance

biomodal

Saffron Walden, UK

1 Regional Head of Sales, North America · 1 US Territory Manager, Northeast

biomodal.com|LinkedIn

biomodal sells multiomic sequencing workflows and analysis software to life scientists and clinical developers.

biomodal launched duet mosaic, two new cfDNA-optimized multiomic sequencing workflows for liquid biopsy, extending its methylation product line.

›

biomodal launched duet mosaic, two new cfDNA-optimized multiomic sequencing workflows for liquid biopsy, extending its methylation product line.

2026-08 · source

biomodal's duet multiomic solutions are now compatible with Element Biosciences' AVITI24 and AVITI sequencing instruments, widening its installed base.

2026-02 · source

biomodal launched a Certified Service Provider program with global partners for its duet multiomics sequencing solutions.

2025-10 · source

Source: company newsroom

Raised $88M Series D (Nov 2021)

›

Led by Temasek; brought total funding raised to $146 million as of that round. · 2021-11-02

“today announced the signing of an $88 million Series D financing, bringing the total funds raised to date to $146 million.”

Source: funding announcement

No openings posted

Booth

Exhibiting at Booth 1409